Consolidated Statements of Cash Flows (Unaudited) - USD ($)	12 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2014
Cash Flows From Operating Activities:
Net income (loss)	$ 666,503	$ (3,849,773)	$ (2,490,145)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Depreciation and Amortization	507,446	768,165	879,329
Impairment of intangibles	0	1,495,703	0
Bad debt expense	68,140	186,780	186,740
Stock compensation expense	1,010,312	2,760,329	1,719,375
Charitable non-cash donations	0	157,950	96,900
Loss on short-term marketable securities	26,128	0	0
Decrease (increase) in:
Trade Receivables	(1,975,517)	710,302	(661,357)
Prepaids and other assets	70,152	(501,957)	(20,747)
Increase (decrease) in:
Accounts payable	(236,810)	(49,296)	84,634
Accrued liabilities	(18,305)	136,517	49,252
Deferred revenue	385,174	(107,123)	63,485
Net cash provided by (used in) operating activities	503,223	1,707,597	(92,534)
Cash Flows From Investing Activities:
Cash from sale of marketable securities	4,612,908	0	0
Payments received on notes receivable	0	300,000	0
Net cash received in acquisition	0	22,119	0
Cash advanced on Note Receivable	0	(2,559,460)	(1,200,000)
Cash from sale of property and equipment	0	0	6,505
Purchase of property and equipment	(80,987)	(369,536)	(459,230)
Capitalization of software costs	(182,942)	0	0
Purchase of long-term investments	(75,584)	0	0
Purchase of marketable securities	(4,639,036)	0	0
Net cash used in investing activities	(365,641)	(2,606,877)	(1,652,725)
Cash Flows From Financing Activities:
Proceeds from employee stock plans	199,848	203,211	153,875
Proceeds from exercise of options and warrants	33,002	0	633,454
Proceeds from issuance of notes payable	0	172,795	338,287
Proceeds from issuance of stock	0	7,606,384	1,493,818
Net increase in lines of credit	0	1,300,000	0
Preferred stock redemption	0	(7,500)	0
Dividends paid	(10,575)	(157,147)	(586,999)
Payments on notes payable and capital leases	(242,041)	(245,450)	(551,202)
Net cash (used in) provided by financing activities	(19,766)	8,872,293	1,481,233
Net increase (decrease) in cash and cash equivalents	117,816	7,973,013	(264,026)
Cash and cash equivalents at beginning of period	11,325,572	3,352,559	3,616,585
Cash and cash equivalents at end of period	11,443,388	11,325,572	3,352,559
Supplemental Disclosure of Cash Flow Information:
Cash paid for income taxes	0	0	6,634
Cash paid for interest	46,508	80,534	75,343
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Preferred stock to pay accrued liabilities	400,000	300,000	0
Common stock to pay accrued liabilities	1,687,741	1,860,191	1,107,698
Dividends accrued on preferred stock	729,288	568,821	617,891
Dividends paid with preferred stock	660,130	442,002	0
Conversion of accounts receivable into notes receivable	0	0	1,622,863
Series B restructure	0	2,141,980	0
Note payable for long-term investment	396,000	0	$ 0
Fair value of assets and liaiblities acquired:
Receivables	152,340	152,340
Prepaid expense	17,500	17,500
Customer relationships	1,314,000	1,314,000
Goodwill	16,077,953	16,077,953
Accounts payable	(128,126)
Deferred revenue	(598,232)
Net assets acquired	$ 16,835,435	$ 16,835,435
Common stock issued	10,821,897	10,821,897
Receivables eliminated in consolidation	$ 6,035,657	$ 6,035,657
Cash received in acquisition	$ 2,219	$ 22,119